{"url_path":"/sec/ptct/8-k/2026-06-16/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-16","source_url":"https://www.sec.gov/Archives/edgar/data/1070081/0001104659-26-074292-index.html","accession_number":"0001104659-26-074292","cik":"0001070081","ticker":"PTCT","issuer_name":"PTC THERAPEUTICS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1070081/0001104659-26-074292-index.html","primary_entity_key":"0001070081","primary_entity_name":"PTC THERAPEUTICS, INC."},"word_count":312,"has_tables":true,"body_markdown":"false\n0001070081\n\n0001070081\n\n2026-06-15\n2026-06-15\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\n \n\n \n\n**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**WASHINGTON, D.C. 20549**\n\n \n\n**FORM 8-K**\n\n \n\n**CURRENT REPORT**\n\n**Pursuant to Section 13 or 15(d) of\nthe Securities Exchange Act of 1934**\n\n \n\nDate of Report (Date of earliest event reported):\n**June 15, 2026**\n\n \n\n**PTC\nTHERAPEUTICS, INC.**\n\n(Exact Name of Company as Specified in Charter)\n\n \n\n**Delaware**\n \n**001-35969**\n \n**04-3416587**\n\n(State\nor Other Jurisdiction\n \n(Commission\n \n(IRS\nEmployer\n\nof Incorporation)\n \nFile\nNumber)\n \nIdentification\nNo.)\n\n \n\n**500\nWarren Corporate Center Drive**\n \n \n \n\n**Warren****,\nNJ**\n \n \n**07059**\n\n(Address\nof Principal Executive Offices)\n \n \n(Zip\nCode)\n\n \n\nRegistrant’s telephone number, including\narea code: **(908****) 222-7000**\n\n \n\n**Not applicable**\n\n(Former Name or Former Address, if Changed Since\nLast Report)\n\n \n\nCheck the appropriate box below if the Form 8-K\nfiling is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (*see*\nGeneral Instruction A.2. below):\n\n \n\n¨Written\ncommunications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\n \n\n¨Soliciting\nmaterial pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n \n\n¨Pre-commencement\ncommunications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n \n\n¨Pre-commencement\ncommunications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\n \n\n**Securities registered pursuant to Section 12(b) of the\nAct:**\n\n \n\n**Title\nof each class**\n \n**Trading\nSymbol(s)**\n \n**Name\nof each exchange on which registered**\n\nCommon\nStock, $0.001 par value per share\n \nPTCT\n \nNasdaq\nGlobal Select Market\n\n \n\nIndicate by check mark whether the registrant is an emerging growth\ncompany as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities\nExchange Act of 1934 (§240.12b-2 of this chapter).\n\n \n\nEmerging growth company ¨\n\n \n\nIf an emerging growth company, indicate by check mark if the registrant\nhas elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant\nto Section 13(a) of the Exchange Act. ¨"}